English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Evaluation of the in vitro interaction of doripenem and amikacin against  Acinetobacter baumannii ,  Pseudomonas aeruginosa , and  Klebsiella pneumoniae  was done by classifying them into four groups: doripenem and amikacin sensitive (DOR-S/AMK-S), doripenem sensitive and amikacin resistant (DOR-S/AMK-R), doripenem resistant and amikacin sensitive (DOR-R/AMK-S), and both doripenem and amikacin resistant (DOR-R/AMK-R). The MIC of each antibiotic and their combination was obtained using the Etest method. The fractional inhibitory concentration index was calculated to classify the results as synergistic, additive, indifferent, or antagonistic interaction. In the DOR-S/AMK-S class, 1 isolate of  A. baumannii  showed synergy and the other 5 showed additive results, 5 isolates of  P. aeruginosa  showed additive and 1 isolate showed indifferent result, and 2 isolates of  K. pneumoniae  showed additive and the other 4 showed indifferent results. In the DOR-S/AMK-R class, 3 isolates of  A. baumannii  showed additive and the other 3 showed indifferent results, 2 isolates of  P. aeruginosa  showed indifferent results, and 1 isolate of  K. pneumoniae  showed additive and the other 5 showed indifferent results. In the DOR-R/AMK-S class, 1 isolate of  A. baumannii  showed additive and the other 5 showed indifferent results, 1 isolate of  P. aeruginosa  showed additive and the other 5 showed indifferent results, and 4 isolates of  K. pneumoniae  showed additive and the other 2 showed indifferent results. In the DOR-R/AMK-R class, 6 isolates of  A. baumannii  showed indifferent results, 1 isolate of  P. aeruginosa  showed additive and the other 5 showed indifferent results, and 1 isolate of  K. pneumoniae  showed additive and the other 5 showed indifferent results. Synergy occurred in only 1 (1.5%) isolate. Additive interaction occurred in 24 (35.3%) isolates, and indifferent interaction occurred in 43 (63.2%) isolates. Doripenem sensitive combined with amikacin sensitive reduced MIC significantly in all bacterial isolates when compared to single MIC of each antibiotic.

the canadian journal of infectious diseases and medical microbiology/canadian journal of infectious diseases and medical microbiology

In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates